Clinical impact of bone and calcium metabolism changes in sarcoidosis - Wikidata - wikimedia - TriplyDB

Clinical impact of bone and calcium metabolism changes in sarcoidosis

Clinical impact of bone and calcium metabolism changes in sarcoidosis

http://www.wikidata.org/entity/Q35532393

about

Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients Intraosseous sarcoidosis of the jaws mimicking aggressive periodontitis: a case report and literature review.Bone health issues in sarcoidosis.Three cases of urolithiasis associated with sarcoidosis: a review of Japanese cases.Randomised controlled trial of vitamin D supplementation in sarcoidosis.Hypercalcemia in a male-to-female transgender patient after body contouring injections: a case report.Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.Hyercalcemia induced by interferon therapy in chronic hepatitis C.Bone density is normal and does not change over 2 years in sarcoidosis.Current best practice in the management of pulmonary and systemic sarcoidosis.Osseous sarcoid with lytic lesions in skull.

P2860

Q33765423-E5E9701D-1F9E-439F-B978-91BEB1170965 Q35747657-A1E43A7B-E55D-4A1D-9A28-643E1C37494C Q35850086-9E8C9BAC-A0C9-46F6-8649-131118F6AD1F Q36945871-AD65F1AA-EAB0-4701-A1E4-1C3C2822BC37 Q37256476-464156D2-EC57-4A26-97E2-D234521738BA Q37685325-3A320189-AB2C-4369-9DB1-02E0E5D32A3E Q41640652-5F383CCD-5F24-402A-9A5A-B45C0CE309D3 Q41817895-CC7AD8CE-1069-41F6-8436-08DA5AA9EFB2 Q43729903-52C2EA99-8DCA-4033-8A06-C585654443BC Q44079914-AEBC32C4-BD9A-4145-83A4-B0EBD22FC5D9 Q46300304-FF8978A0-FF48-4361-8378-FB0BB0013EAE

P2860

Clinical impact of bone and calcium metabolism changes in sarcoidosis

http://www.wikidata.org/entity/Q35532393

description

1998 nî lūn-bûn

@nan

1998 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Clinical impact of bone and calcium metabolism changes in sarcoidosis

@ast

Clinical impact of bone and calcium metabolism changes in sarcoidosis

@en

type

label

Clinical impact of bone and calcium metabolism changes in sarcoidosis

@ast

Clinical impact of bone and calcium metabolism changes in sarcoidosis

@en

prefLabel

Clinical impact of bone and calcium metabolism changes in sarcoidosis

@ast

Clinical impact of bone and calcium metabolism changes in sarcoidosis

@en

P1433

Q35532393-4526D2D0-ECA7-44A8-BF49-5ECB13D90173

P1476

Q35532393-57634E91-2DDF-4FDC-881A-AB5BF42025FF

P2093

Q35532393-51A8AA44-68F2-4A76-8C67-63393230EDFF

P2860

Q35532393-0ABCA263-3E38-4A1F-A936-CA51951798FE

Q35532393-1A45A10C-209E-4B68-8FFB-3B9A3FA5C164

Q35532393-212FBF6F-39F9-4306-8A13-3DD8709D2EC2

Q35532393-24210FA1-E590-4C94-8751-7D208C70A708

Q35532393-3375879C-B47F-445A-8280-92412D937C42

Q35532393-4A225D0E-A797-4D0D-93BF-FDA5F90C80B9

Q35532393-56721097-CF4D-440D-BD11-4DEA16087F95

Q35532393-599227CB-B704-4E27-9AE5-52CCA197682C

Q35532393-5C7BE8C0-FA4C-426D-BA14-EC1F61BD73F4

Q35532393-67E1B187-9D1E-46C2-ABC0-C34437332AA8

P304

Q35532393-7ACDE37A-3815-4562-B1F0-A1EA90E06CD6

P31

Q35532393-6A139E7F-DD4D-4151-8F6D-3B8BBFF45988

P356

Q35532393-714DD5B4-FCBE-49E7-B866-9F6473450A1A

P407

Q35532393-800AF331-CF27-467E-9080-C30B25D28C89

P433

Q35532393-9BF8A739-4F81-4543-86D9-04220BCB15AC

P478

Q35532393-5BEB74C5-2E8F-48C5-86DA-BB6DC339CEBF

P577

Q35532393-EABD008B-4DD1-40B3-B4EA-F63CA30C9C43

P5875

Q35532393-0EDBF7CF-288E-4C45-8414-1BD8F9B08B20

P698

Q35532393-262B1F30-FAD5-4D19-BF73-14DC05750892

P932

Q35532393-12490BF0-DC71-4501-B555-C3B2ADB54865

P356

P1433

P1476

Clinical impact of bone and calcium metabolism changes in sarcoidosis

@en

P2093

Rizzato G

http://www.w3.org/2001/XMLSchema#string

P2860

Nephrolithiasis as a presenting feature of chronic sarcoidosis.

Biochemical findings in sarcoidosis.

Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D.

Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis.

1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes

Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.

A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones.

The cause of hypercalcuria in sarcoid and its treatment with cortisone and sodium phytate.

Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis

In vitro metabolism of 25-hydroxyvitamin D3 by isolated rat kidney cells

P304

425-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.53.5.425

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

1998-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13577550

http://www.w3.org/2001/XMLSchema#string

P698

9708239

http://www.w3.org/2001/XMLSchema#string

P932

1745206

http://www.w3.org/2001/XMLSchema#string